Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia
- PMID: 31084782
- DOI: 10.1016/j.vaccine.2019.03.079
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia
Comment in
-
Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.Vaccine. 2019 Dec 10;37(52):7534. doi: 10.1016/j.vaccine.2019.09.108. Epub 2019 Nov 14. Vaccine. 2019. PMID: 31733945 No abstract available.
Comment on
-
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.Vaccine. 2018 Oct 8;36(42):6307-6313. doi: 10.1016/j.vaccine.2018.08.084. Epub 2018 Sep 10. Vaccine. 2018. PMID: 30213457
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
